Integral Ad Science (NASDAQ:IAS) Shares Gap Down After Analyst Downgrade

Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) shares gapped down prior to trading on Wednesday after Piper Sandler lowered their price target on the stock from $18.00 to $16.00. The stock had previously closed at $12.62, but opened at $11.00. Piper Sandler currently has an overweight rating on the stock. Integral Ad Science shares last traded at $11.26, with a volume of 271,987 shares trading hands.

Other equities research analysts also recently issued reports about the stock. Morgan Stanley upped their price objective on shares of Integral Ad Science from $12.00 to $13.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 23rd. Benchmark reaffirmed a "hold" rating on shares of Integral Ad Science in a report on Monday, August 5th. Oppenheimer decreased their price target on Integral Ad Science from $20.00 to $18.00 and set an "outperform" rating for the company in a research report on Wednesday. Barclays boosted their price objective on Integral Ad Science from $12.00 to $13.00 and gave the stock an "equal weight" rating in a research report on Monday, August 5th. Finally, Raymond James raised their target price on Integral Ad Science from $13.00 to $15.00 and gave the company an "outperform" rating in a research report on Friday, August 2nd. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $15.70.

Insider Activity at Integral Ad Science

In other Integral Ad Science news, CFO Tania Secor sold 5,240 shares of the stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $52,976.40. Following the completion of the transaction, the chief financial officer now owns 248,223 shares in the company, valued at $2,509,534.53. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, CEO Lisa Utzschneider sold 10,481 shares of the company's stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $105,962.91. Following the sale, the chief executive officer now directly owns 239,709 shares in the company, valued at $2,423,457.99. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Tania Secor sold 5,240 shares of the business's stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $52,976.40. Following the transaction, the chief financial officer now directly owns 248,223 shares of the company's stock, valued at approximately $2,509,534.53. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 23,006 shares of company stock worth $240,296. Company insiders own 2.00% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in IAS. nVerses Capital LLC purchased a new stake in shares of Integral Ad Science during the 3rd quarter valued at $45,000. Ameritas Investment Partners Inc. lifted its stake in Integral Ad Science by 40.1% during the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company's stock worth $67,000 after purchasing an additional 1,924 shares during the last quarter. Quantbot Technologies LP bought a new stake in Integral Ad Science during the third quarter worth about $106,000. Stoneridge Investment Partners LLC purchased a new stake in Integral Ad Science in the third quarter worth approximately $125,000. Finally, XTX Topco Ltd bought a new position in Integral Ad Science during the second quarter valued at approximately $113,000. 95.78% of the stock is currently owned by hedge funds and other institutional investors.

Integral Ad Science Price Performance

The stock has a market capitalization of $1.74 billion, a PE ratio of 55.00, a P/E/G ratio of 1.90 and a beta of 1.52. The firm's 50 day simple moving average is $11.13 and its 200 day simple moving average is $10.46. The company has a debt-to-equity ratio of 0.10, a current ratio of 3.76 and a quick ratio of 3.76.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, topping analysts' consensus estimates of $0.08 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.52%. The company had revenue of $133.50 million for the quarter, compared to analysts' expectations of $138.06 million. During the same quarter last year, the company earned ($0.09) EPS. The firm's revenue was up 11.0% compared to the same quarter last year. As a group, equities analysts forecast that Integral Ad Science Holding Corp. will post 0.23 EPS for the current fiscal year.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.